Pfizer Inc. buy BMO Capital Markets
Start price
16.10.23
/
50%
€31.50
Target price
16.10.24
€31.25
Performance (%)
-13.15%
Price
03.07.24
€25.82
Summary
This prediction is currently active. The price of Pfizer Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.15%. Dividends of €1.54 are taken into consideration when calculating the performance. This prediction currently runs until 16.10.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pfizer Inc. | 0.545% | 0.545% |
iShares Core DAX® | 1.175% | -0.931% |
iShares Nasdaq 100 | 1.232% | 9.715% |
iShares Nikkei 225® | 1.563% | 3.040% |
iShares S&P 500 | 0.034% | 5.962% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at BMO Capital Markets from $44.00 to $33.00. They now have an "outperform" rating on the stock.
Ratings data for PFE provided by MarketBeat